Ignite Creation Date:
2025-12-25 @ 3:05 AM
Ignite Modification Date:
2025-12-26 @ 1:44 AM
Study NCT ID:
NCT07157033
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-05
First Post:
2025-08-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
Sponsor:
Xerient Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-28
First Submit QC Date:
None
Study First Post Date:
2025-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-28
Last Update Post Date:
2025-09-05
Last Update Post Date Type:
ESTIMATED